Comment on: Benchmarking tocilizumab use for giant cell arteritis.

Janagan, Shalini; Guly, Catherine; Skeoch, Sarah; Robson, Joanna C

Janagan, Shalini; Guly, Catherine; Skeoch, Sarah; Robson, Joanna C.

Afiliação

Janagan S; Department of Rheumatology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Guly C; Bristol Eye Hospital, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Skeoch S; Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Royal United Hospitals, Bath, UK.
Robson JC; Department of Rheumatology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.

Rheumatol Adv Pract ; 6(3): rkac069, 2022.

Article em En | MEDLINE | ID: mdl-36133959

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Rheumatol Adv Pract Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido